| Report ID | 253150 |
| Drug Identification Number | 00608165 |
| Brand name | TEVA-OXYCOCET |
| Common or Proper name | TEVA-OXYCOCET TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
| Strength(s) | 325MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-19 |
| Estimated end date | 2026-01-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v33 | 2025-10-16 | French | Compare |
| v32 | 2025-10-16 | English | Compare |
| v31 | 2025-10-10 | French | Compare |
| v30 | 2025-10-10 | English | Compare |
| v29 | 2025-10-02 | French | Compare |
| v28 | 2025-10-02 | English | Compare |
| v27 | 2025-09-25 | French | Compare |
| v26 | 2025-09-25 | English | Compare |
| v25 | 2025-08-29 | French | Compare |
| v24 | 2025-08-29 | English | Compare |
| v23 | 2025-08-28 | French | Compare |
| v22 | 2025-08-28 | English | Compare |
| v21 | 2025-08-08 | French | Compare |
| v20 | 2025-08-08 | English | Compare |
| v19 | 2025-08-07 | French | Compare |
| v18 | 2025-08-07 | English | Compare |
| v17 | 2025-08-06 | French | Compare |
| v16 | 2025-08-06 | English | Compare |
| v15 | 2025-07-29 | French | Compare |
| v14 | 2025-07-29 | English | Compare |